SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-23-005538
Filing Date
2023-02-17
Accepted
2023-02-17 20:19:05
Documents
2
Period of Report
2023-02-15

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4873
2 ex24-1.htm EX-24.1 11198
  Complete submission text file 0001493152-23-005538.txt   17620
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Issuer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address OCEAN BIOMEDICAL, INC. 55 CLAVERICK ST., ROOM 325 PROVIDENCE RI 02903
Business Address
Kurtis Jonathan (Reporting) CIK: 0001873968 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40793 | Film No.: 23644897